SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Sui s a Layer 1 blockchain developed by Mysten Labs, a team founded by former lead engineers from Meta’s blockchain research division. It is designed for global adoption by providing a secure, high-speed environment for digital asset ownership and removing technical barriers for Web3 applications. The platform utilizes the Move programming language to create a safe framework and supports horizontal scaling to keep fees stable and speeds high as the network grows. Significant institutional support comes from major venture capital firms including Andreessen Horowitz, Coinbase Ventures, Circle Ventures, and YZi Labs.  The system functions by organizing data into independent objects rather than a single ledger of accounts. This object-centric data model enables parallel execution, allowing the network to process many transactions simultaneously instead of waiting for one to finish before starting the next. This architecture is built for rapid transaction finalization to ensure near-instant results. To maintain long-term stability, the network collects fees into a storage fund that rewards validators for keeping data on the network indefinitely.  Sui offers several advanced tools including zkLogin for easier account access and sponsored transactions that allow users to interact with apps without managing complex wallets or immediate fees. Developers can also create tailored object types that work across the entire network, which encourages innovation and deep composability. These features are designed to create a more user-friendly experience for interacting with decentralized applications and digital games.  The SUI token is central to the ecosystem, serving as the primary asset for transaction fees and on-chain utility within decentralized exchanges and lending platforms. Users participate in a proof-of-stake mechanism by locking their tokens to support validators and secure the blockchain in exchange for rewards. Additionally, token holders have a role in governance, allowing them to participate in voting on network rules and future protocol upgrades. Value moves through the system through these staking rewards and transaction fees to ensure the platform scales sustainably

SUI is generating significant social media buzz as traders debate its potential as a high-growth Layer-1 alternative to Solana, with many highlighting its integration into institutional products and recent developments within its ecosystem. Community discussions are split between bullish sentiment fueled by institutional accumulation and skepticism from those wary of market volatility and recent price fluctuations.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

The community is actively debating the potential for a breakout or consolidation phase as $PEPE trends alongside broader meme coin volatility. Traders are expressing mixed sentiments, with some focusing on long-term accumulation strategies during pullbacks while others remain skeptical about the coin's price stability.

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

Shiba Inu is seeing heightened market attention driven by institutional interest following its inclusion in a T. Rowe Price crypto ETF filing, though the community remains sharply divided between long-term holders citing Shibarium utility and skeptics calling the project a stagnant asset. Active discussions are dominated by debates over token burn mechanisms, ongoing layer-2 development, and speculative rotation into smaller meme-themed projects on platforms like Base.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is attracting significant investor attention following a positive final pre-BLA meeting with the FDA for sonelokimab in hidradenitis suppurativa, which de-risked the regulatory path toward a planned BLA submission. The community is actively discussing the drug's potential for best-in-class efficacy, durability, and commercial differentiation compared to incumbents, with traders closely monitoring upcoming phase 3 readouts and long-term data as catalysts for a potential revaluation or M&A activity.

StupidCoin

StupidCoin is gaining significant traction within the Solana ecosystem as traders rally behind its active community-led development and viral marketing efforts. Enthusiasts are highlighting the project's recent growth, community collaborations, and ecosystem integrations as key drivers for heightened market interest.

The KARRAT protocol is a decentralized gaming infrastructure layer, supported by $KARRAT and empowered by a truly decentralized community with a shared vision embracing gaming, entertainment and AI products catering for the new era.  To accelerate the evolution of gaming, entertainment, and AI-driven experiences with blockchain technology and a truly empowered community.  The KARRAT protocol pioneers a decentralized framework in gaming and entertainment, combining blockchain with community-driven collaboration. $KARRAT can animate ecosystems of games and products and the protocol makes tools available to support these industries and the adoption of KARRAT technology provides a unique, personalized gaming experience.

KARRAT

KARRAT is gaining community attention as investors anticipate a major breakout driven by its deep integration into the Web3 gaming sector, specifically through the StudioChain infrastructure and its flagship title, My Pet Hooligan. Many participants are actively accumulating tokens, citing strong strategic partnerships with major AI and tech firms as a primary catalyst for long-term growth despite recent market volatility.

Got that dog in you? - Fueled by a mantra of tokenized self-belief, doginme is representative of the community's collective efforts to embrace and embolden that dog in them. doginme stands for knowing yourself and having that unshakable drive to keep pushing forward. doginme was originally launched in February 2024 when the Farcaster founder was asked if he owned a dog, to which he replied affirmatively: "no but I got that dog in me"

doginme

DOGINME is trending as the community rallies around its unique 'tokenized self-belief' narrative, emphasizing grit and holding conviction during market volatility. Enthusiasts are actively highlighting the project's growth on the Base chain and speculating on potential exchange listings, with many members bonding over the core 'I got that dog in me' spirit.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is trending following the announcement of a pivotal Phase 3 design for its lead drug candidate, CAD-1005, aimed at treating heparin-induced thrombocytopenia. While some investors are optimistic about the upcoming trial path and orphan drug designation, the community is currently debating the stock's volatility and widespread skepticism surrounding the heavy automated bot activity on discussion boards.

Rewarding holding and rejecting the culture of fast flips. Longterm sustainability by using a multi-phase dynamic rewards system. Meme that inspires creativity and innovation. Fun community involvement, including games, memes, and also serious holder mindset. We have automated rewards to holders, buyback and burns and are giving back to ocean cleanup initiatives. All pump fun creator rewards are used for the buyback and burn of the token, rewarding holders, and donating to nonprofits that clean our oceans.

MAKE HOLDING GREAT AGAIN

MHGA is trending as the community highlights its recent CoinGecko listing and ongoing Solana-based holder rewards. Investors are actively discussing the project's utility and commitment to charitable ocean cleanup efforts.

GIGA is a meme token deployed on the Solana blockchain intended to honor the legend Ernest Khalimov the original “Gigachad”, by utilizing the strength of memes and “Chad” energy.  GIGA is a community run project.

GigaChad

GIGA is gaining significant momentum as the community highlights its enduring cultural relevance, recent high-profile media mentions, and the expansion of its real-world fitness supplement brand. Investors are actively discussing the asset's asymmetric potential as a long-term hold, often drawing parallels to historical meme coin trajectories and emphasizing the strength of its dedicated, long-standing community.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Fineotex Chemical shares plunged 90%: Why? Ashish Kacholia places a bet

The management of Mumbai-based speciality chemicals manufacturer Fineotex Chemical undertook a bonus issue and a stock split simultaneously. However, it created a confusion among a big section of investors who thought that the stock crashed today morning.

Shares of Fineotex Chemical&nbsp;surged 16.6% on Thursday, its highest intra-day gains since May 2023.The small-cap specialty chemicals <a href="https://stocktwits.com/symbol/FCL.NSE">stock</a> climbed to its highest in nearly two months.Why Is The Stock Surging?After market hours on Wednesday, the company announced that its board of directors will meet on September 27 to consider key corporate actions, which include an interim dividend, a sub-division of shares with a face value of ₹2, and the issue of bonus shares.If approved, this will mark the first stock split and bonus issue by Fineotex in a decade. In 2015, the company carried out a 1:5 stock split and issued a 1:1 bonus, with its most recent dividend payout being ₹0.40 per share.Ace investor Ashish Kacholia holds a 2.74% stake, or about 31.35 lakh shares, in Fineotex.Retail BuoyantRetail sentiment shifted to ‘bullish’ on Stocktwits following the official announcement. It was ‘neutral’ the day before.<figure class="image"><img style="aspect-ratio:931/91;" src="https://news.stocktwits-cdn.com/Fineotex_png_3e2be8d9a1.webp" alt="Fineotex.png" width="931" height="91"><figcaption>Fineotex's Sentiment Meter and Message Volumes at 02:00 p.m. IST on September 25 | Source: Stocktwits</figcaption></figure>Despite today’s gains, the stock has declined over 24% year-to-date. It has fallen in five of the last seven sessions.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Tariff uncertainty has prompted several analysts to cut their price targets for Five9 stock. 

This Smallcap Specialty Chemical Stock Has Seen Its Biggest Intra-day Gains In Over Two Years

Board meeting on September 27 to consider a stock split as well as the issue of bonus shares.

Equity

Fineotex Chemical Limited Sustains Growth Amid Global Trade Challenges

Fineotex Chemical Limited (FCL), one of India’s top multinational specialty performance chemical manufacturers, continues to demonstrate strong resilience and strategic foresight in the face of global trade uncertainties. While tariffs disrupt the global …

Fineotex Chemical Ltd. engages in the manufacture of chemicals for textiles, construction, water-treatment, fertilizer, leather and paint industry. Its products include Textile, Water & Oil Based Drilling Fluid, and Cleaning & Hygiene chemicals. The company was founded by Surendra Kumar Tibrewala in 1979 and is headquartered in Mumbai, India.

Current Price	28.16
Prev Close	27.75
Open	27.75
Dividend Yield	0.35%
50-Day Moving Average	22.68
Beta	-0.05
Avg. Volume	3.43M
PE Ratio	32.08

52-Week High	35.79
52-Week Low	19.10
Market Capitalization	32.87B
EPS (Annual)	0.9527
Price to Book	4.14
Revenue Per Employee	18.74M

FCL.NSE
Fineotex Chemical Ltd

Feed

News

Sentiment

Fundamentals

Info

Latest FCL.NSE News

FCL.NSEFineotex Chemical Ltd